Covid-19 Severity and Outcome in Patients with Hypertension, Diabetes and Obesity in Erbil City

Summary
Background: Clinical co-morbidity of COVID-19 diseases is the main reason for high severity and
mortality outcome.
Objective: To assess the relationship between hypertension, diabetes mellitus and obesity with severity and outcome of COVID-19 disease.
Methodology: A prospective cross sectional study carried out in West Emergency Hospital in Erbil city-Kurdistan region/Iraq through duration period of six months from 1st of March to 31st of August, 2021on sample of one hundred patients with COVID-19 disease. The hypertension, diabetes mellitus and obesity were assessed by history, clinical examination and laboratory testing.
Results: This study showed that 24% of studied hospitalized patients had moderate COVID-19 disease and 76% of them had severe COVID-19 disease. The present study showed a significant association between hypertension and COVID-19 severity with no relationship between both obesity and diabetes mellitus with COVID-19 severity. The common clinical and laboratory markers of hospitalized
patients with severe COVID-19 disease are increased respiratory rate, low SPO2, lymphopenia and high C-reactive protein level. Conclusions: Hypertension is the common clinical co-morbidity related to severe COVID-19 disease. The common clinical and laboratory markers of hospitalized patients with severe COVID-19 disease are increased respiratory rate, low SPO2, lymphopenia and high C-reactive protein level. Triage of patients with COVID-19 diseases in emergency department must be based on clinical comorbidity